PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme

Journal of the National Cancer Institute

Volumn 93, Issue 16, 2001, Pages 1246-1256

  Smith, Justin S ^a   Tachibana, Issei ^a   Passe, Sandra M ^a   Huntley, Brenda K ^a   Borell, Thomas J ^a   Iturria, Nancy ^a   O'Fallon, Judith R ^a   Schaefer, Paul L ^b   Scheithauer, Bernd W ^a   James, C David ^a   Buckner, Jan C ^a   Jenkins, Robert B ^a  

^a MAYO CLINIC   (United States)

^b Toledo Community Hospital Oncology Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME 10; CHROMOSOME 7; CHROMOSOME ARM; CHROMOSOME LOSS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PERFORMANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 0035880788     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.16.1246     Document Type: Article

References (43)

1. Genetic alterations in adult diffuse glioma: Occurrence, significance, and prognostic implications
2. Grading of astrocytomas. A simple and reproducible method
3. Highly anaplastic astrocytoma: A review of 357 patients treated between 1997 and 1989
4. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationships and prognostic value
5. Supratentorial low-grade gliomas in adults: An analysis of prognostic factors and timing of radiation
6. Gene amplification as a prognostic factor in primary brain tumors
7. Tumours of the nervous system
8. A molecular genetic model of astrocytoma histopathology
9. Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma
10. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma
11. Phase III study radiation therapy (RT) plus BCNU with or without recombinant interferon alpha (IFN) in high grade glioma: An NCCTG study
12. Appraisal of methods for study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
13. Toxicity and response criteria of the Eastern Cooperative Oncology Group
14. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
15. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescene in situ hybridization
16. Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using flourescene in situ hybridization and novel microsatellite markers
17. Microwave-based DNA extraction from paraffin-embedded tissue for PCR amplification
18. Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue
19. p53 and PTEN gene mutations in gemistocytic astrocytomas
20. Nonparametric estimation from incomplete observations
21. Evaluation of survival data and two new rank order statistics arising in its consideration
22. Relative risk trees for censored survival data
23. Regression models and life tables
24. Bootstrap methods: Another look at the jackknife
25. A bootstrap resampling procedure for model building: Application to the Cox regression model
26. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
27. Specific chromosomal abnormalities in malignant human gliomas
28. Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: Correlation with radiation treatment outcome
29. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma
30. Multivariate analysis of prognostic factors in 106 patients with malignant glioma
31. Allelic deletion analysis of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance
32. Differential expression of MMAC/PTEN in glioblastoma multiforme: Relationship to localization and prognosis
33. Analysis of oncogene and tumour suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations
34. Mutational analysis of the PTEn gene in gliomas: Molecular and pathological correlations
35. PTEN gene mutations are seen in high-grade but not in low-grade gliomas
36. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
37. Mutational spectra of PTEN/MMAC1 gene: A tumor suppressor with lipid phosphatase activity
38. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
39. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
40. Analysis of complex relationships between age, p53, epidermal growth factor receptor mutations in human gliobastomas
41. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas
42. Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytoma. An Analysis of DNA content (ploidy), cellular proliferation, and p53 expression